
Polypharmacology in Drug Discovery
Kurzinformation



inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
Polypharmacology can be the two-faced Janus in drug discovery and pharmacology: an adverse, off-target safety risk in some cases or a necessity for effectively treating complex diseases like psychosis and cancer. This book overviews these facets of polypharmacology to help drug discovery researchers both address adverse polypharmacology and approach the discovery of polypharmacological drugs, with a third section of the book uses selected case studies to illustrate drug discovery opportunities. This resource fosters interdisciplinary drug discovery research by guiding researchers in neighboring areas to polypharmacology.
Produktdetails

So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
Jens-Uwe Peters, PhD, works in the Medicinal Chemistry Department at F. Hoffmann-La Roche. In his ten years at Roche, he has been involved in numerous drug discovery projects, has contributed to Early Safety Profiling initiatives, and has researched oppor
- hardcover
- 606 Seiten
- Erschienen 2006
- Wiley-VCH
- Gebunden
- 386 Seiten
- Erschienen 2012
- Wiley-VCH
- Taschenbuch
- 384 Seiten
- Erschienen 2011
- -
- hardcover
- 2021 Seiten
- Erschienen 2005
- McGraw-Hill Medical
- Hardcover
- 511 Seiten
- Erschienen 1995
- Academic Press
- hardcover
- 384 Seiten
- Erschienen 2012
- Wiley
- Hardcover -
- Erschienen 2011
- Wiley-Blackwell
- hardcover
- 1056 Seiten
- Erschienen 2022
- Wiley
- paperback
- 172 Seiten
- Erschienen 2003
- Wiley & Sons